Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.240
+0.050 (4.20%)
At close: May 12, 2025, 4:00 PM
1.240
0.00 (0.00%)
After-hours: May 12, 2025, 4:02 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $83.79 million as of May 12, 2025. Its market cap has decreased by -18.36% in one year.
Market Cap
83.79M
Enterprise Value
-128.20M
1-Year Change
-18.36%
Ranking
Category
Stock Price
1.24
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $83.79M, a decrease of -79.22%. That is a compound annual growth rate of -34.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 80.42M | -33.54% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |